Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective
Amyotrophic lateral sclerosis (ALS) is a progressive and lethal disease of motor neuron degeneration, leading to paralysis of voluntary muscles and death by respiratory failure within five years of onset. Frontotemporal dementia (FTD) is characterised by degeneration of frontal and temporal lobes, l...
Main Authors: | Stephanie A. Fernandes, Andrew G. L. Douglas, Miguel A. Varela, Matthew J. A. Wood, Yoshitsugu Aoki |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Journal of Nucleic Acids |
Online Access: | http://dx.doi.org/10.1155/2013/208245 |
Similar Items
-
Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
by: Alexander Schmitz, et al.
Published: (2021-02-01) -
The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD.
by: Eino Solje, et al.
Published: (2015-01-01) -
Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS
by: Vijay Kumar, et al.
Published: (2017-12-01) -
Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD
by: Thomas Westergard, et al.
Published: (2016-10-01) -
RNA-mediated toxicity in C9orf72 ALS and FTD
by: Zachary T. McEachin, et al.
Published: (2020-11-01)